The calm before the storm: clinical observations of Middle East respiratory syndrome (MERS) patients

Journal of Chemotherapy

Volumn 30, Issue 3, 2018, Pages 179-182

  Al Tawfiq, Jaffar A ^a,b   Hinedi, Kareem ^a  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hospital care; MERS CoV; Middle East Respiratory Syndrome Coronavirus

Indexed keywords

ADALIMUMAB; ALPHA2B INTERFERON; OXYGEN; PREDNISONE; RIBAVIRIN; ANTIVIRUS AGENT;

ADULT; ARTICLE; BREATHING RATE; CASE REPORT; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRACKLE; DIABETES MELLITUS; DIZZINESS; E GENE; FATIGUE; FEVER; GENE; HUMAN; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME; NAUSEA; NOSE SMEAR; OPEN READING FRAME; ORF1 GENE; OXYGEN SATURATION; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; THROAT CULTURE; VOMITING; WEAKNESS; CORONAVIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PROGNOSIS; SAUDI ARABIA; TRANSMISSION; VIROLOGY;

ANTIVIRAL AGENTS; CORONAVIRUS INFECTIONS; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PROGNOSIS; RIBAVIRIN; SAUDI ARABIA;

EID: 85041327677     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1080/1120009X.2018.1429236     Document Type: Article

References (21)

1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation o. novel coronavirus fro. man with pneumonia in Saudi Arabia. Eng. Med. 2012;367:1814–20. doi:10.1056/NEJMoa1211721.
2. World Health Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV). WHO; 2017 [cited 2017 Apr 30]. Available from: http://www.who.int/emergencies/mers-cov/en/
3. Al-Tawfiq JA, Hinedi K, Ghandour J, Khairalla H, Musleh S, Ujayli A, et al. Middle East respiratory syndrome-coronavirus (MERS-CoV). case-controlstudy of hospitalized patients. Clin Infect Dis. 2014;59:160–5. doi:10.1093/cid/ciu226.
4. Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160:389–97. doi:10.7326/M13-2486.
5. Shalhoub S, Farahat F, Al-Jiffri A, Simhairi R, Shamma O, Siddiqi N, et al. IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia. retrospective study. Antimicrob Chemother. 2015;70:2129–32. doi:10.1093/jac/dkv085.
6. Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection. single-center experience in Saudi Arabia. In. Infect Dis. 2014;29:301–6. doi:10.1016/j.ijid.2014.09.003.
7. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia. descriptive study. Lancet Infect Dis. 2013;13:752–61. doi:10.1016/S1473-3099(13)70204-4.
8. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, Assiri A, Alhakeem RF, Albarrak A, et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. Infect Dis. 2014;210:1590–1594. doi:10.1093/infdis/jiu292.
9. World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV); 2015 [cited 2016 Dec 20]. Available from: http://apps.who.int/iris/bitstream/10665/176982/1/WHO_MERS_LAB_15.1_eng.pdf?ua=1
10. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. Family cluster of Middle East respiratory syndrome coronavirus infections. Eng. Med. 2013;368:2487–94. doi:10.1056/NEJMoa1303729.
11. Omrani AS, Matin MA, Haddad Q, Al-Nakhli D, Memish ZA, Albarrak AM. family cluster of middle east respiratory syndrome coronavirus infections related t. likely unrecognized asymptomatic or mild case. In. Infect Dis. 2013;17:e668–72. doi:10.1016/j.ijid.2013.07.001.
12. Memish ZA, Cotten M, Watson SJ, Kellam P, Zumla A, Alhakeem RF, et al. Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia. descriptive genomic study. In. Infect Dis. 2014;23:63–68. doi:10.1016/j.ijid.2014.03.1372.
13. Hall AJ, Tokars JI, Badreddine SA, Bin Saad Z, Furukawa E, Al Masri M, et al. Health care worker contact with MERS patient, Saudi Arabia. Emerg Infect Dis. 2014;20:2148–51. doi:10.3201/eid2012.141211.
14. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DAT, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. Eng. Med. 2013;369:407–16. doi:10.1056/NEJMoa1306742.
15. Drosten C, Muth D, Corman VM, Hussain R, Al Masri M, HajOmar W, et al. An observational, laboratory-based study of outbreaks of Middle East respiratory syndrome coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014. Clin Infect Dis. 2015;60:369–77. doi:10.1093/cid/ciu812.
16. Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT. Preliminary epidemiologic assessment of MERS-CoV outbreak in South Korea, May–June 2015. Euro Surveill. 2015;20(25):7–13.
17. Al-Tawfiq JA, Memish ZA. Managing MERS-CoV in the healthcare setting. Hosp Pract. 2015;43:158–63. doi:10.1080/21548331.2015.1074029.
18. Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. In. Infect Dis. 2014;20:42–46. doi:10.1016/j.ijid.2013.12.003.
19. Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)–possible lessons fro. systematic review of SARS-CoV therapy. In. Infect Dis. 2013;17:e792–8. doi:10.1016/j.ijid.2013.07.002.
20. Al-Tawfiq JA, Memish ZA. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Expert Rev Anti Infect Ther. 2017;2016(14787210):1271712. doi:10.1080/14787210.2017.1271712.
21. Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection. retrospective cohort study. Lancet Infect Dis. 2014;14:1090–1095. doi:10.1016/S1473-3099(14)70920-X.